Evidence map›Paper›PMID 32587788›Full record

ArticleWorld journal of gastrointestinal pathophysiology2020

P2X7 receptor antagonist recovers ileum myenteric neurons after experimental ulcerative colitis.

Roberta Figueiroa Souza, Mariá Munhoz Evangelinellis, Cristina Eusébio Mendes, Marta Righetti, Múcio Cevulla Silva Lourenço, Patricia Castelucci

Open access · diamondAbstract read
In one paragraph

Article in World journal of gastrointestinal pathophysiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. In focus in HCB.Histochemistry and cell biology · 2022
    Article
  6. Review
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Roberta Figueiroa SouzaDepartment of Anatomy, University of São Paulo, São Paulo 05508-900, Brazil.
Mariá Munhoz EvangelinellisDepartment of Surgery, Faculty of Veterinary Medicine and Animal Science, University of São Paulo, São Paulo 05508-900, Brazil.
Cristina Eusébio MendesDepartment of Anatomy, University of São Paulo, São Paulo 05508-900, Brazil.
Marta RighettiDepartment of Anatomy, University of São Paulo, São Paulo 05508-900, Brazil.
Múcio Cevulla Silva LourençoDepartment of Anatomy, University of São Paulo, São Paulo 05508-900, Brazil.
Patricia CastelucciDepartment of Anatomy, University of São Paulo, São Paulo 05508-900, Brazil. pcastel@usp.br.
Universidade de São Paulo · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe P2X7 receptor is expressed by enteric neurons and enteric glial cells. Studies have demonstrated that administration of a P2X7 receptor antagonist, brilliant blue G (BBG), prevents neuronal loss.

aimTo report the effects of BBG in ileum enteric neurons immunoreactive (ir) following experimental ulcerative colitis in

methods2,4,6-trinitrobenzene sulfonic acid (TNBS group,

resultsThe numbers of nNOS-, ChAT-, HuC/D-ir neurons and glial fibrillary acidic protein-ir glial cells were decreased in the TNBS group and recovered in the BBG group. The neuronal profile area (μm

conclusionOur data conclude that ileum myenteric neurons and glial cells were affected by ulcerative colitis and that treatment with BBG had a neuroprotective effect. Thus, these results demonstrate that the P2X7 receptor may be an important target in therapeutic strategies.

Indexed as

Brilliant blue GChemical codingExperimental ulcerative colitisIleumMyenteric plexusP2X7 receptor

Identifiers

PMID32587788
PMCPMC7303980
OpenAlexW3036851091

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.